When researchers discovered enough proof that a medication used to treat bone marrow cancer and Kaposi sarcoma is safe and effective in treating hereditary hemorrhagic telangiectasia (HHT), a rare bleeding disorder that affects 1 in 5,000 people worldwide, they decided to terminate an early
Washington DC [USA], Nov 29 (ANI): A team of researchers has identified a protein that could prevent cancer by restricting a type of herpes virus from replicating.